One-third of hepatitis C prescriptions rejected by insurers, study says

Public and private health insurers have denied more than one-third of claims for hepatitis C drugs because they can cost several thousand dollars a month.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news